Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H24O2 |
| Molecular Weight | 272.382 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CCC2=O
InChI
InChIKey=JRIZOGLBRPZBLQ-QXUSFIETSA-N
InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-16H,2-9H2,1H3/t13-,14+,15+,16-,18-/m0/s1
| Molecular Formula | C18H24O2 |
| Molecular Weight | 272.382 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Estranediols profiling in calves' urine after 17beta-nandrolone laureate ester administration. | 2010-08 |
|
| Novel steroid-sensing model and characterization of protein interactions based on fluorescence anisotropy decay. | 2010-04-01 |
|
| Influence of delivery mode on the urinary excretion of nandrolone metabolites. | 2010-04 |
|
| Biochemical and physiological aspects of endogenous androgens. | 2010 |
|
| Steroid metabolism in chimeric mice with humanized liver. | 2009-11 |
|
| Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism. | 2009-07-24 |
|
| Urinary nandrolone metabolite detection after ingestion of a nandrolone precursor. | 2009-04 |
|
| Two homologous fungal carbonyl reductases with different substrate specificities. | 2009-03-16 |
|
| Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone. | 2009-03 |
|
| Doping in sport--2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone. | 2009-03 |
|
| A new mixed micellar electrokinetic chromatography method for analysis of natural and synthetic anabolic steroids. | 2009-01-15 |
|
| Gene expression in hair follicle dermal papilla cells after treatment with stanozolol. | 2008-12-23 |
|
| Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione. | 2008-12-15 |
|
| Elimination kinetic of 17beta-estradiol 3-benzoate and 17beta-nandrolone laureate ester metabolites in calves' urine. | 2008-05 |
|
| Profiling of 19-norsteroid sulfoconjugates in human urine by liquid chromatography mass spectrometry. | 2008-04-21 |
|
| The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration. | 2008-04-01 |
|
| The presence of 19-norandrostenedione and its sulphate form in yolk-sac fluid of the early equine conceptus. | 2008-01 |
|
| Microbial oxidation of anabolic steroids. | 2008 |
|
| Synthesis and analytics of 2,2,3,4,4-d5-19-nor-5alpha-androsterone--an internal standard in doping analysis. | 2007-05 |
|
| Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite. | 2007-04 |
|
| Studies related to the origin of C18 neutral steroids isolated from extracts of urine from the male horse: the identification of urinary 19-oic acids and their decarboxylation to produce estr-4-en-17beta-ol-3-one (19-nortestosterone) and estr-4-ene-3,17-dione (19-norandrost-4-ene-3,17-dione) during sample processing. | 2007-03-14 |
|
| Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS/MS and GC-MS methods, respectively. | 2007-03 |
|
| Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects. | 2006-11 |
|
| Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids. | 2006-09 |
|
| Dimerization and enzymatic activity of fungal 17beta-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily. | 2005-12-16 |
|
| Transformations of 4- and 17alpha-substituted testosterone analogues by Fusarium culmorum. | 2005-11 |
|
| Endogenous occurrence of some anabolic steroids in swine matrices. | 2005-09 |
|
| Unintentional doping through the use of contaminated nutritional supplements. | 2005-07 |
|
| Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids. | 2005-03 |
|
| Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. | 2004-07 |
|
| Significance of individual amino acid residues for coenzyme and substrate specificity of 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus. | 2003-02-01 |
|
| Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits? | 2003-02 |
|
| Effects of norandrostenedione and norandrostenediol in resistance-trained men. | 2002-09 |
|
| Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control. | 2002-01-25 |
|
| [Urinary nandrolone metabolites in antidoping control]. | 2001-09 |
|
| Detection and determination of anabolic steroids in nutritional supplements. | 2001-07 |
|
| The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol on body composition and athletic performance in previously weight-trained male athletes. | 2001-05 |
|
| The metabolism of orally ingested 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol in healthy, resistance-trained men. | 2001-02 |
|
| 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: structural and functional aspects. | 2001-01-30 |
|
| Searching for the physiological function of 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: studies of substrate specificity and expression analysis. | 2001-01-22 |
|
| Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:08:59 GMT 2025
by
admin
on
Mon Mar 31 18:08:59 GMT 2025
|
| Record UNII |
U90987PVU5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C002828
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
734-32-7
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
211-995-8
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
DB01448
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
100000091511
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
SUB25857
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
19-NORANDROSTENEDIONE
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
1470026
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
U90987PVU5
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
12164
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
92834
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY | |||
|
DTXSID50862392
Created by
admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |